Prior H1N1 influenza infection and susceptibility of cleveland family study participants during the H2N2 pandemic of 1957 : An experiment of nature. Commentary
Identifieur interne : 000040 ( PascalFrancis/Checkpoint ); précédent : 000039; suivant : 000041Prior H1N1 influenza infection and susceptibility of cleveland family study participants during the H2N2 pandemic of 1957 : An experiment of nature. Commentary
Auteurs : Edwin D. Kilbourne [États-Unis] ; Suzanne L. Epstein [États-Unis]Source :
- The Journal of infectious diseases [ 0022-1899 ] ; 2006.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
Abstract
During a pandemic, influenza vaccines that rely on neutralizing antibodies to protect against matched viruses might not be available early enough. Much broader (heterosubtypic) immune protection is seen in animals. Do humans also have cross-subtype immunity? To investigate this issue, archival records from the Cleveland Family Study, which was conducted before and during the 1957 pandemic (during which a shift from subtype H1N1 to H2N2 occurred), were analyzed. Only 5.6% of the adults who had had symptomatic influenza A in earlier study years developed influenza during the pandemic, despite living in households with participants who had influenza. In contrast, 55.2% of the children who had had symptomatic influenza A contracted it again. These findings suggest an impact of accumulated heterosubtypic immunity during a pandemic. Such immunity, as well as its implications for vaccination, should be further investigated.
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
Pascal:06-0108310Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Prior H1N1 influenza infection and susceptibility of cleveland family study participants during the H2N2 pandemic of 1957 : An experiment of nature. Commentary</title><author><name sortKey="Kilbourne, Edwin D" sort="Kilbourne, Edwin D" uniqKey="Kilbourne E" first="Edwin D." last="Kilbourne">Edwin D. Kilbourne</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Microbiology and Immunology, New York Medical College</s1><s2>Valhalla</s2><s3>USA</s3><sZ>1 aut.</sZ></inist:fA14><country>États-Unis</country><wicri:noRegion>Valhalla</wicri:noRegion></affiliation></author><author><name sortKey="Epstein, Suzanne L" sort="Epstein, Suzanne L" uniqKey="Epstein S" first="Suzanne L." last="Epstein">Suzanne L. Epstein</name><affiliation wicri:level="2"><inist:fA14 i1="02"><s1>Laboratory of Immunology and Developmental Biology, Division of Cellular and Gene Therapies, Office of Cellular, Tissue, and Gene Therapies, Center for Biologies Evaluation and Research, Food and Drug Administration</s1><s2>Rockville, Maryland</s2><s3>USA</s3><sZ>2 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><region type="state">Maryland</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">INIST</idno><idno type="inist">06-0108310</idno><date when="2006">2006</date><idno type="stanalyst">PASCAL 06-0108310 INIST</idno><idno type="RBID">Pascal:06-0108310</idno><idno type="wicri:Area/PascalFrancis/Corpus">000049</idno><idno type="wicri:Area/PascalFrancis/Curation">000025</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">000040</idno><idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000040</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Prior H1N1 influenza infection and susceptibility of cleveland family study participants during the H2N2 pandemic of 1957 : An experiment of nature. Commentary</title><author><name sortKey="Kilbourne, Edwin D" sort="Kilbourne, Edwin D" uniqKey="Kilbourne E" first="Edwin D." last="Kilbourne">Edwin D. Kilbourne</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Microbiology and Immunology, New York Medical College</s1><s2>Valhalla</s2><s3>USA</s3><sZ>1 aut.</sZ></inist:fA14><country>États-Unis</country><wicri:noRegion>Valhalla</wicri:noRegion></affiliation></author><author><name sortKey="Epstein, Suzanne L" sort="Epstein, Suzanne L" uniqKey="Epstein S" first="Suzanne L." last="Epstein">Suzanne L. Epstein</name><affiliation wicri:level="2"><inist:fA14 i1="02"><s1>Laboratory of Immunology and Developmental Biology, Division of Cellular and Gene Therapies, Office of Cellular, Tissue, and Gene Therapies, Center for Biologies Evaluation and Research, Food and Drug Administration</s1><s2>Rockville, Maryland</s2><s3>USA</s3><sZ>2 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><region type="state">Maryland</region></placeName></affiliation></author></analytic><series><title level="j" type="main">The Journal of infectious diseases</title><title level="j" type="abbreviated">J. infect. dis.</title><idno type="ISSN">0022-1899</idno><imprint><date when="2006">2006</date></imprint></series></biblStruct></sourceDesc><seriesStmt><title level="j" type="main">The Journal of infectious diseases</title><title level="j" type="abbreviated">J. infect. dis.</title><idno type="ISSN">0022-1899</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Infection</term><term>Influenza</term><term>Microbiology</term><term>Sensitivity</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Sensibilité</term><term>Microbiologie</term><term>Infection</term><term>Grippe</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">During a pandemic, influenza vaccines that rely on neutralizing antibodies to protect against matched viruses might not be available early enough. Much broader (heterosubtypic) immune protection is seen in animals. Do humans also have cross-subtype immunity? To investigate this issue, archival records from the Cleveland Family Study, which was conducted before and during the 1957 pandemic (during which a shift from subtype H1N1 to H2N2 occurred), were analyzed. Only 5.6% of the adults who had had symptomatic influenza A in earlier study years developed influenza during the pandemic, despite living in households with participants who had influenza. In contrast, 55.2% of the children who had had symptomatic influenza A contracted it again. These findings suggest an impact of accumulated heterosubtypic immunity during a pandemic. Such immunity, as well as its implications for vaccination, should be further investigated.</div></front></TEI><inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0022-1899</s0></fA01><fA02 i1="01"><s0>JIDIAQ</s0></fA02><fA03 i2="1"><s0>J. infect. dis.</s0></fA03><fA05><s2>193</s2></fA05><fA06><s2>1</s2></fA06><fA08 i1="01" i2="1" l="ENG"><s1>Prior H1N1 influenza infection and susceptibility of cleveland family study participants during the H2N2 pandemic of 1957 : An experiment of nature. Commentary</s1></fA08><fA11 i1="01" i2="1"><s1>KILBOURNE (Edwin D.)</s1><s9>comment.</s9></fA11><fA11 i1="02" i2="1"><s1>EPSTEIN (Suzanne L.)</s1></fA11><fA14 i1="01"><s1>Department of Microbiology and Immunology, New York Medical College</s1><s2>Valhalla</s2><s3>USA</s3><sZ>1 aut.</sZ></fA14><fA14 i1="02"><s1>Laboratory of Immunology and Developmental Biology, Division of Cellular and Gene Therapies, Office of Cellular, Tissue, and Gene Therapies, Center for Biologies Evaluation and Research, Food and Drug Administration</s1><s2>Rockville, Maryland</s2><s3>USA</s3><sZ>2 aut.</sZ></fA14><fA20><s2>7-8,49-53 [7 p.]</s2></fA20><fA21><s1>2006</s1></fA21><fA23 i1="01"><s0>ENG</s0></fA23><fA43 i1="01"><s1>INIST</s1><s2>2052</s2><s5>354000133238380060</s5></fA43><fA44><s0>0000</s0><s1>© 2006 INIST-CNRS. All rights reserved.</s1></fA44><fA45><s0>29 ref.</s0></fA45><fA47 i1="01" i2="1"><s0>06-0108310</s0></fA47><fA60><s1>P</s1><s3>CC</s3><s3>CT</s3></fA60><fA61><s0>A</s0></fA61><fA64 i1="01" i2="1"><s0>The Journal of infectious diseases</s0></fA64><fA66 i1="01"><s0>USA</s0></fA66><fC01 i1="01" l="ENG"><s0>During a pandemic, influenza vaccines that rely on neutralizing antibodies to protect against matched viruses might not be available early enough. Much broader (heterosubtypic) immune protection is seen in animals. Do humans also have cross-subtype immunity? To investigate this issue, archival records from the Cleveland Family Study, which was conducted before and during the 1957 pandemic (during which a shift from subtype H1N1 to H2N2 occurred), were analyzed. Only 5.6% of the adults who had had symptomatic influenza A in earlier study years developed influenza during the pandemic, despite living in households with participants who had influenza. In contrast, 55.2% of the children who had had symptomatic influenza A contracted it again. These findings suggest an impact of accumulated heterosubtypic immunity during a pandemic. Such immunity, as well as its implications for vaccination, should be further investigated.</s0></fC01><fC02 i1="01" i2="X"><s0>002A05</s0></fC02><fC02 i1="02" i2="X"><s0>002B05</s0></fC02><fC03 i1="01" i2="X" l="FRE"><s0>Sensibilité</s0><s5>05</s5></fC03><fC03 i1="01" i2="X" l="ENG"><s0>Sensitivity</s0><s5>05</s5></fC03><fC03 i1="01" i2="X" l="SPA"><s0>Sensibilidad</s0><s5>05</s5></fC03><fC03 i1="02" i2="X" l="FRE"><s0>Microbiologie</s0><s5>06</s5></fC03><fC03 i1="02" i2="X" l="ENG"><s0>Microbiology</s0><s5>06</s5></fC03><fC03 i1="02" i2="X" l="SPA"><s0>Microbiología</s0><s5>06</s5></fC03><fC03 i1="03" i2="X" l="FRE"><s0>Infection</s0><s5>07</s5></fC03><fC03 i1="03" i2="X" l="ENG"><s0>Infection</s0><s5>07</s5></fC03><fC03 i1="03" i2="X" l="SPA"><s0>Infección</s0><s5>07</s5></fC03><fC03 i1="04" i2="X" l="FRE"><s0>Grippe</s0><s5>14</s5></fC03><fC03 i1="04" i2="X" l="ENG"><s0>Influenza</s0><s5>14</s5></fC03><fC03 i1="04" i2="X" l="SPA"><s0>Gripe</s0><s5>14</s5></fC03><fC07 i1="01" i2="X" l="FRE"><s0>Virose</s0></fC07><fC07 i1="01" i2="X" l="ENG"><s0>Viral disease</s0></fC07><fC07 i1="01" i2="X" l="SPA"><s0>Virosis</s0></fC07><fN21><s1>065</s1></fN21><fN44 i1="01"><s1>OTO</s1></fN44><fN82><s1>OTO</s1></fN82></pA></standard></inist><affiliations><list><country><li>États-Unis</li></country><region><li>Maryland</li></region></list><tree><country name="États-Unis"><noRegion><name sortKey="Kilbourne, Edwin D" sort="Kilbourne, Edwin D" uniqKey="Kilbourne E" first="Edwin D." last="Kilbourne">Edwin D. Kilbourne</name></noRegion><name sortKey="Epstein, Suzanne L" sort="Epstein, Suzanne L" uniqKey="Epstein S" first="Suzanne L." last="Epstein">Suzanne L. Epstein</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/PascalFrancis/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000040 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/biblio.hfd -nk 000040 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= H2N2V1
|flux= PascalFrancis
|étape= Checkpoint
|type= RBID
|clé= Pascal:06-0108310
|texte= Prior H1N1 influenza infection and susceptibility of cleveland family study participants during the H2N2 pandemic of 1957 : An experiment of nature. Commentary
}}
| This area was generated with Dilib version V0.6.33. |  |